Calling on Cancer's A-Team (U.S. News & World Report)
When Gary Hinze began coughing up blood afterworking out, his doctor sent him to an oncologist near his home in Grass Valley, California. The diagnosis: Stage IIIA lung cancer. "He pretty much told me I was a goner," says Hinze, then 62. Read more.
Lobectomy Suffices for Surgery of Small Papilla Thyroid Cancers (ACS Surgery News)
New research by Julie Ann Sosa, M.D., M.A. & Mohamed Abdelgadir Adam, M.D.J., has found that extensive surgery beyond lobectomy appears to offer no survival advantage for small papillary thyroid cancers. These findings were discussed at the annual meeting of the American Surgical Association earlier this year. Read more.
Common Plastic Chemical May Create Breast Cancer Cells
A new study from Duke University suggests a chemical found in many plastics can make breast cancer cells resistant to treatment. News articles on the findings included stories in Newswire, News-Medical, Headlines & Global News and many more. Coverage of the study was also featured on WUNC 91.5.
Lifetime Cancer Risk from Heart Imaging Low for Most Children, but Rises with More Complex Tests
Children with heart disease are exposed to low levels of radiation during X-rays, which do not significantly raise their lifetime cancer risk. However, children who undergo repeated complex imaging tests that deliver higher doses of radiation may have a slightly increased lifetime risk of cancer, according to researchers at Duke Medicine. Read more.
Prostate Cancer Drug Delivers Benefits Before Chemotherapy
A drug currently used to treat men with late-stage prostate cancer proved effective in stemming disease progression and extending survival in patients who had not yet received chemotherapy, according to results from a large international study that included Duke Cancer Institute researchers. Read more.
High Cholesterol Fuels Growth, Spread of Breast Cancer
Early studies reveal the link between high cholesterol and breast cancer. Senior author Donald McDonnell, Ph.D., chair of the Department of Pharmacology and Cancer Biology at Duke, says that what has been found is a molecule that mimics the hormone estrogen and "can independently drive the growth of breast cancer. Finding were published in the Nov. 29, 2013 edition of the journal Science and covered by Science Daily, Nature World News, News & Observer, FOX News and more.